Liu Jing, Gao Yi, Wang Shuan, Sun Er-Wei, Wang Yu, Zhang Zhi, Shan Yi-Qiang, Zhong Shi-Zheng
Department of Organ Transplantation, Zhujiang Hospital, 253, Gongye Highway, Guangzhou 510282, Guangdong Province, China.
World J Gastroenterol. 2005 Feb 28;11(8):1161-6. doi: 10.3748/wjg.v11.i8.1161.
To study effect of operation-synchronizing transfusion of apoptotic spleen cells from donor rats on acute rejection of recipient rats after liver transplantation.
Two of Wistar rats were chosen randomly for normal liver pathology control and ten of SD rats chosen randomly for liver function control as blank group (no operation). The rest of Wistar and SD rats were divided into four groups: control group (only liver transplantation), Dex group (donors receiving intraperitoneal injection of dexamethasone), SpC group (recipients receiving infusion of spleen cells of donors), Dex-SpC group (recipients receiving infusion of apoptotic spleen cells of donors), with each group except blank group, containing 10 SD rats and 10 Wistar rats, respectively. Wistar rats received liver transplantation from SD rats, in the meantime they received infusion of spleen cells of donors, which were induced by an intraperitoneal injection of dexamethasone (3 mg/(d.kg).b.w) for three days before liver transplantation. The serum alanine transaminase (ALT), total bilirubin (T bili), liver pathological changes and survival time were analysed. Statistical analysis was carried out using SPSS 10.0 for Windows. Differences of the parametric data of ALT in means were examined by one-way ANOVA. Differences of ALT between two groups were examined by LSD. Differences of the nonparametric data of T bili in means and scores of pathology classification for acute rejection were examined by Kruskal-Willis H test. The correlations between ALT and T bili were analysed by Bivariate. Kaplan-Meier curves were used to demonstrate survival distribution. The log-rank test was used to compare the survival data.
There were significant differences in ALT of the five groups (F = 23.164 P = 0.000), and ALT in Dex-SpC group was significantly higher than that in blank control, control, Dex, and SpC groups (P = 0.000), and ALT in SpC group was significantly higher than that in blank control (P = 0.000), control (P = 0.004), and Dex groups (P = 0.02). Results of nonparametric analysis of T bili showed that there were differences in T bili of the five groups (chi(2) = 33.265 P = 0.000). T bili in Dex-SpC group was significantly higher than that in blank control, control, Dex, and SpC groups. T bili in SpC group was higher than that in blank control, control, and Dex groups. There were significant differences in scores of pathology classification for acute rejection in each of the groups (chi(2) = 25.933,P = 0.000). The pathologically more serious acute rejection was found in Dex-SPC group than in other groups. No sign of acute rejection was observed in the blank control group. Slight acute rejection was observed in the control group. Slight-moderate acute rejection was observed in the Dex group. Moderate-acute rejection was observed in the SpC group. Severe-acute rejection was observed in the Dex-SpC group. The survival time in Dex-SpC group was shorter than in other groups (statistic = 11.13, P = 0.011). ALT and T bili were positively correlated (r = 0.747, P = 0.000, two-tailed).
In order to reduce quantity of blood loss from rats after liver transplantation, only one of ALT or T bili is needed for liver function measurement of rats. Simultaneous injection of apoptotic spleen cells from donors induced by dexamethasone to liver transplantation rats aggravates acute rejection. One important mechanism of aggravation of acute rejection may be that apoptotic cells are not removed in time and that dead cells including apoptotic cells release inflammatory factors.
研究供体大鼠凋亡脾细胞同步输注对肝移植受体大鼠急性排斥反应的影响。
随机选取2只Wistar大鼠作为正常肝脏病理对照,随机选取10只SD大鼠作为肝功能对照即空白组(未手术)。其余Wistar大鼠和SD大鼠分为4组:对照组(仅行肝移植)、地塞米松组(供体接受腹腔注射地塞米松)、脾细胞组(受体接受供体脾细胞输注)、地塞米松 - 脾细胞组(受体接受供体凋亡脾细胞输注),除空白组外每组分别含10只SD大鼠和10只Wistar大鼠。Wistar大鼠接受SD大鼠的肝移植,同时接受供体脾细胞输注,供体脾细胞于肝移植前3天腹腔注射地塞米松(3 mg/(d·kg·b.w))诱导产生。分析血清丙氨酸转氨酶(ALT)、总胆红素(T bili)、肝脏病理变化及生存时间。采用SPSS 10.0 for Windows进行统计分析。ALT参数数据均值差异采用单因素方差分析检验。两组间ALT差异采用LSD检验。T bili非参数数据均值差异及急性排斥病理分类评分差异采用Kruskal - Willis H检验。ALT与T bili的相关性采用双变量分析。采用Kaplan - Meier曲线展示生存分布。采用对数秩检验比较生存数据。
五组ALT有显著差异(F = 23.164,P = 0.000),地塞米松 - 脾细胞组ALT显著高于空白对照、对照、地塞米松及脾细胞组(P = 0.000),脾细胞组ALT显著高于空白对照(P = 0.000)、对照(P = 0.004)及地塞米松组(P = 0.02)。T bili非参数分析结果显示五组T bili有差异(chi(2) = 33.265,P = 0.000)。地塞米松 - 脾细胞组T bili显著高于空白对照、对照、地塞米松及脾细胞组。脾细胞组T bili高于空白对照、对照及地塞米松组。各组急性排斥病理分类评分有显著差异(chi(2) = 25.933,P = 0.000)。地塞米松 - 脾细胞组急性排斥病理表现比其他组更严重。空白对照组未观察到急性排斥迹象。对照组观察到轻微急性排斥。地塞米松组观察到轻度 - 中度急性排斥。脾细胞组观察到中度急性排斥。地塞米松 - 脾细胞组观察到重度急性排斥。地塞米松 - 脾细胞组生存时间短于其他组(统计量 = 11.13,P = 0.011)。ALT与T bili呈正相关(r =